126 related articles for article (PubMed ID: 21459723)
1. GPC3 fused to an alpha epitope of HBsAg acts as an immune target against hepatocellular carcinoma associated with hepatitis B virus.
Yang JW; Yang DY; Lu FG; Li CH; Chen H; Xie N; Zhao X
Hepatobiliary Pancreat Dis Int; 2011 Apr; 10(2):164-70. PubMed ID: 21459723
[TBL] [Abstract][Full Text] [Related]
2. A new membrane re-anchored protein originating from GPC3 against hepatoma cells HepG2.
Yang D; Yang J; Lu F; Li C; Yang J; Liang J
Mol Med Rep; 2011; 4(6):1067-73. PubMed ID: 21904776
[TBL] [Abstract][Full Text] [Related]
3. [Expression and localization of strong epitope hAFP(542-550); on eukaryotic cytoplasmic membrane].
Yang DY; Li CH; Lan F; Zhang YQ; Lu FG; Yang ZR; Huang LQ
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2009 Jul; 25(7):592-5, 599. PubMed ID: 19737475
[TBL] [Abstract][Full Text] [Related]
4. T Cells Engineered to Express a T-Cell Receptor Specific for Glypican-3 to Recognize and Kill Hepatoma Cells In Vitro and in Mice.
Dargel C; Bassani-Sternberg M; Hasreiter J; Zani F; Bockmann JH; Thiele F; Bohne F; Wisskirchen K; Wilde S; Sprinzl MF; Schendel DJ; Krackhardt AM; Uckert W; Wohlleber D; Schiemann M; Stemmer K; Heikenwälder M; Busch DH; Richter G; Mann M; Protzer U
Gastroenterology; 2015 Oct; 149(4):1042-52. PubMed ID: 26052074
[TBL] [Abstract][Full Text] [Related]
5. GPC3 DNA vaccine elicits potent cellular antitumor immunity against HCC in mice.
Li SQ; Lin J; Qi CY; Fu SJ; Xiao WK; Peng BG; Liang LJ
Hepatogastroenterology; 2014; 61(130):278-84. PubMed ID: 24901124
[TBL] [Abstract][Full Text] [Related]
6. Potential role of novel hepatocellular carcinoma-associated gene IDD01 in promoting tumorigenesis of HepG2 cell line.
Chen XY; Li JS; Ma J; Duan FL; Zhong P
Chin Med J (Engl); 2006 Oct; 119(20):1709-14. PubMed ID: 17097018
[TBL] [Abstract][Full Text] [Related]
7. [Construction of a plasmid vector of fused protein genes driven by human insulin-like growth factor II P3 promoter].
Zhou HK; Yang DH; Tang SH; Huang W; Lu XH
Zhonghua Yi Xue Za Zhi; 2006 Jan; 86(2):106-10. PubMed ID: 16620715
[TBL] [Abstract][Full Text] [Related]
8. Development of GPC3-Specific Chimeric Antigen Receptor-Engineered Natural Killer Cells for the Treatment of Hepatocellular Carcinoma.
Yu M; Luo H; Fan M; Wu X; Shi B; Di S; Liu Y; Pan Z; Jiang H; Li Z
Mol Ther; 2018 Feb; 26(2):366-378. PubMed ID: 29339014
[TBL] [Abstract][Full Text] [Related]
9. [PreC/C gene-targeting RNA interference suppresses hepatitis B virus replication and expression in human hepatoma cells].
Bian ZQ; Liu S; Liu MQ; Xiao A; Jiao Y; Yan WY; Zheng ZX
Zhonghua Yi Xue Za Zhi; 2012 Mar; 92(11):768-72. PubMed ID: 22781359
[TBL] [Abstract][Full Text] [Related]
10. [Effect of glypican-3 on the proliferation of human hepatoma cell line MHCC97-L in vitro].
QIN RZ; LIU FY; CHEN B; XIE JM; YANG Y; ZHEGN DY; LUO RC
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):448-52. PubMed ID: 21421480
[TBL] [Abstract][Full Text] [Related]
11. Glypican3 in genetically modified human monocyte-derived dendritic cells induced specific cytotoxity against glypican3 overexpressing human hepatocellular carcinoma cells in vitro.
Guo DW; Zhang SY; Hou XZ; Li HW; Jiang XF; Sun WY; We YT; Liang J
Saudi Med J; 2008 Sep; 29(9):1235-40. PubMed ID: 18813403
[TBL] [Abstract][Full Text] [Related]
12. [Construction and expression of eukaryotic expression vector for pEGFP-GPC3].
Liu CH; Zhang ZM; Liu JY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2012 May; 28(5):462-5. PubMed ID: 22558983
[TBL] [Abstract][Full Text] [Related]
13. Transfection of apoptosis related gene Fas ligand in human hepatocellular carcinoma cells and its significance in apoptosis.
Chen J; Su XS; Jiang YF; Gong GZ; Zheng YH; Li GY
World J Gastroenterol; 2005 May; 11(17):2653-5. PubMed ID: 15849828
[TBL] [Abstract][Full Text] [Related]
14. [Immune response of HBsAg gene-modified dendritic cell-based vaccine in HepG2. 2. 15 hepatocellular carcinoma cells].
Yang JY; Liu WC; Cao DY; Si XM; Teng ZH
Zhonghua Zhong Liu Za Zhi; 2007 Oct; 29(10):728-32. PubMed ID: 18396682
[TBL] [Abstract][Full Text] [Related]
15. Increased antitumor activities of glypican-3-specific chimeric antigen receptor-modified T cells by coexpression of a soluble PD1-CH3 fusion protein.
Pan Z; Di S; Shi B; Jiang H; Shi Z; Liu Y; Wang Y; Luo H; Yu M; Wu X; Li Z
Cancer Immunol Immunother; 2018 Oct; 67(10):1621-1634. PubMed ID: 30078052
[TBL] [Abstract][Full Text] [Related]
16. [Construction of an expression vector of GPC-3 CTL epitope].
Wang WJ; Li CY; Li MS
Nan Fang Yi Ke Da Xue Xue Bao; 2009 Aug; 29(8):1548-50. PubMed ID: 19726288
[TBL] [Abstract][Full Text] [Related]
17. [Construction of eukaryotic expression vector for EBF3 and EGFP fusion protein and its expression in HepG2 cells].
Mao LP; Wang HM; Wang YG; Wang XY
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Oct; 24(10):954-7. PubMed ID: 18845077
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis and its pathway in X gene-transfected HepG2 cells.
Lin N; Chen HY; Li D; Zhang SJ; Cheng ZX; Wang XZ
World J Gastroenterol; 2005 Jul; 11(28):4326-31. PubMed ID: 16038029
[TBL] [Abstract][Full Text] [Related]
19. [Hepatocellular carcinoma, hepatitis B virus and the immune system].
Grob PJ
Schweiz Med Wochenschr; 1986 Aug; 116(34):1133-45. PubMed ID: 3020684
[TBL] [Abstract][Full Text] [Related]
20. Concomitant use of heat-shock protein 70, glutamine synthetase and glypican-3 is useful in diagnosis of HBV-related hepatocellular carcinoma with higher specificity and sensitivity.
Moudi B; Heidari Z; Mahmoudzadeh-Sagheb H; Alavian SM; Lankarani KB; Farrokh P; Randel Nyengaard J
Eur J Histochem; 2018 Jan; 62(1):2859. PubMed ID: 29569872
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
